Samuel Manoranjan

Samuel Manoranjan has a diverse work experience in the field of quality assurance and management. Samuel started their career at Cytosol Laboratories Inc as a QA Supervisor, where they supervised daily analysis and testing of raw materials, finished products, and managed the document control system. Samuel then moved on to Antigenics as a Quality Assurance Specialist, where they reviewed and ensured compliance to SOPs and cGMPs and initiated formal investigations. Samuel joined Biogen in 2003 as a Quality Assurance Specialist III in Supply Chain Quality, providing oversight for various manufacturing operations. Samuel later progressed to roles such as Senior Quality Assurance Specialist I, Associate Director Supply Chain Quality, Manager, Senior Manager, and Global Head External Quality at Biogen, where they were responsible for setting strategies, managing QA staff, and providing quality technical support. Samuel also worked at Alnylam Pharmaceuticals as an Associate Director of Quality Assurance. Currently, they are the Vice President of Quality at Stoke Therapeutics, leading the establishment of the Quality department and ensuring compliance in all GXP functional areas. Samuel collaborates with GXP functional areas to facilitate quality and compliance activities and develops strategies for quality governance and operations. Throughout their career, Samuel has demonstrated strong leadership skills and expertise in quality management.

Samuel Manoranjan completed their education at various institutions between 1995 and 2020. Samuel attended Hebron School in India for their high school education, where they obtained GCSE A-Levels. Afterward, they enrolled at Eastern Nazarene College, where they pursued a Bachelor of Science degree in Biology from 1995 to 2000. Later, they attended Massachusetts College of Pharmacy and Health Sciences, earning a Master of Science degree in Regulatory Affairs and Health Policy between 2003 and 2005. Samuel then returned to Massachusetts College of Pharmacy and Health Sciences for their second Master of Science degree in Pharmacoeconomics, which they completed from 2013 to 2020. Additionally, they obtained a Graduate Certificate in Project Management from Northeastern University, although specific details such as the institution and the year of completion are not provided.